Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia

Abstract To investigate the impact of viral and bacterial co-infection in hospitalised children with Mycoplasma pneumoniae pneumonia (RMPP). Retrospective analysis of 396 children with RMPP in our hospital admitted between 1 January 2011 and 31 December 2016 was performed. Nasal aspirate samples were collected for pathogen detection and clinical data were collected. We analysed clinical characteristics, lung imaging characteristics and pathogenic species among these children. Of the 396 RMPP cases, 107 (27.02%) had co-infection with other pathogen, with Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus being the most common bacteria of infection and human bocavirus (HBoV), human rhinovirus, respiratory syncytial virus being the most common viruses of infection. Children with co-infection were younger than that with single infection (P = 0.010). Children with both virus and bacteria co-infection had been the youngest (P = 0.040). Children with co-infection had a longer fever process, higher leukocyte count, higher C-reactive protein compared with single infection (P < 0.05). Children with co-infection had a higher percentage of pnemothorax and diffuse large area of inflammation in chest X-ray manifestation compared with children with single infection (P < 0.05). S. pneumonia and HBoV was the leading cause of co-infection in RMPP. Co-infections led to more disease severity in children with RMPP compared with single infections.

[1]  Zhimin Chen,et al.  Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children , 2016, Scientific Reports.

[2]  Y. Yazdanpanah,et al.  Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia , 2016, Critical Care.

[3]  K. Shen,et al.  Bacterial co-infection in hospitalized children with Mycoplasma pneumoniae pneumonia , 2016, Indian Pediatrics.

[4]  K. Shen,et al.  Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014. , 2015, International journal of clinical and experimental medicine.

[5]  Maureen H Diaz,et al.  Investigations of Mycoplasma pneumoniae Infections in the United States: Trends in Molecular Typing and Macrolide Resistance from 2006 to 2013 , 2014, Journal of Clinical Microbiology.

[6]  Robert E Black,et al.  Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.

[7]  L. Ying Mixed infections in children with mycoplasma pneumonial pneumonia , 2013 .

[8]  C. Richard,et al.  Pneumopathie à mycoplasme : une cause rare de syndrome de détresse respiratoire aiguë (SDRA) et de résistance potentielle aux antibiotiques , 2013 .

[9]  C. Richard,et al.  [Mycoplasma-related pneumonia: a rare cause of acute respiratory distress syndrome (ARDS) and of potential antibiotic resistance]. , 2013, Revue des maladies respiratoires.

[10]  Zhi-min Chen,et al.  [Mixed infections in children with Mycoplasma pneumoniae pneumonia]. , 2012, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[11]  M. Morozumi,et al.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[12]  Mitchell F. Balish,et al.  Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. , 2008, FEMS microbiology reviews.

[13]  T. Fukaya,et al.  Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children , 2008, Journal of Infection.

[14]  Y. Chiou,et al.  Necrotizing pneumonitis caused by Mycoplasma pneumoniae in pediatric patients: report of five cases and review of literature. , 2004, The Pediatric infectious disease journal.

[15]  M. Korppi Mixed microbial aetiology of community‐acquired pneumonia in children , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.